Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • ACA Enrollment
  • Ebola
  • PFAS in Drinking Water
  • Drug-Related Driving Deaths
  • Black Maternal Health

WHAT'S NEW

  • ACA Enrollment
  • Ebola
  • PFAS in Drinking Water
  • Drug-Related Driving Deaths
  • Black Maternal Health

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Mar 26 2024

Full Issue

Viewpoints: Weight-Loss Drugs Don't Help Everyone; We Mustn't Let Anti-Vax Beliefs Become Normalized

Editorial writers discuss weight-loss drugs, vaccine misinformation, and reproductive health care.

NPR: My Patients Think Ozempic Is A Wonder Drug. But It Can't Fix Fat Phobia

The new weight-loss drugs have a veneer of respectability – doctors prescribe them, after all – that makes them seem different from HerbaLife or Weight Watchers. But, like all the weight-loss promises that came before them, they're being drastically oversold. (Mara Gordon, 3/23)

The Washington Post: How To Counter Vaccine Misinformation In Political Discourse

This fact might be hard to believe, but there’s no denying it: Anti-vaccine sentiments are likely to play a key role in this year’s election. President Biden is fending off challenges from not one but two opponents regularly spouting anti-vaccine messages. (Leana S. Wen, 3/26)

Scientific American: Alabama’s Embryo Personhood Decision Threatens Patients, Medicine And Advances In IVF 

Alabama’s Supreme Court ruled in February that frozen embryos from in vitro fertilization (IVF) are considered “unborn children.” The decision allowed for lawsuits when the loss of an embryo was caused by “the wrongful act, omission, or negligence of any person.” (H. Irene Su, 3/25)

Stat: Eliminate The Waiting Period For Sterilization Covered By Medicaid 

It’s time to acknowledge when a law intended to right an egregious wrong has become harmful — and change it. That’s the case for a law that requires people covered by Medicaid to wait at least 30 days after signing a consent to sterilization form to actually undergo the procedure. But there’s no waiting period for people covered by private insurance. (Amanda Masse and Nadi Nina Kaonga, 3/26)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 20
  • Tuesday, May 19
  • Monday, May 18
  • Friday, May 15
  • Thursday, May 14
  • Wednesday, May 13
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF